SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Top 10 Most Recent Blog Posts
Stock Market Forecast for June 2024: Key Highlights
Category: Markets Total Views: 128By : Editor Updated: 06-02-2024
Beyond the Hype: Meme Coins with Real Utility
Category: Crypto Total Views: 149By : Editor Updated: 06-02-2024
Top Emerging Technologies to Invest In: Betting on the Future in 2024
Category: Investing Total Views: 152By : Editor Updated: 06-02-2024
Investing in Fintech Startups: Opportunities and Risks
Category: Investing Total Views: 143By : Editor Updated: 06-02-2024
Best Side Hustles to Boost Your Income in 2024
Category: Personal Finance Total Views: 217By : Editor Updated: 06-02-2024
Exploring Alternative Investments: Real Estate, Commodities, and More
Category: Investing Total Views: 186By : Editor Updated: 06-01-2024
How AI is Revolutionizing Stock Market Predictions
Category: Markets Total Views: 182By : Editor Updated: 06-01-2024
5 Green Stocks for June 2024: Investing in Clean Energy
Category: Stocks Total Views: 221By : Editor Updated: 06-01-2024
Best Stocks to Invest in June 2024: Insights & Analysis
Category: Stocks Total Views: 369By : Editor Updated: 06-01-2024
Nikola Corporation (NKLA): A Comprehensive Overview
Category: Stocks Total Views: 281By : Editor Updated: 06-01-2024